Versant Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Versant Capital Management's HALO Position: Q3 2026 in Review
Versant Capital Management increased its Halozyme (HALO) stake by 0.65% in Q3 2026, buying an estimated $1.06K and bringing the position to 1,704 shares worth $188K. The position accounts for 0.02% of the portfolio, ranked #641.
Versant Capital Management first reported a position in HALO in Q2 2023 and has held it in 14 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Versant Capital Management held 1,704 shares of Halozyme worth $188K as of Q3 2026.
- Versant Capital Management bought 11 Halozyme shares in Q3 2026, an estimated $1.06K.
- Halozyme made up 0.02% of Versant Capital Management's portfolio in Q3 2026, its #641 holding.
- Versant Capital Management first reported a position in Halozyme in Q2 2023 and has held it in 14 quarters since.
- 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.